Table 2.
Antimicrobial resistance pattern of Salmonella spp. isolated from food handlers in Wolaita Sodo meal serving facilities (n = 387), 2017
| AMP | TMP–SXT | AMX | K | CIP | CRO | NA | C | |
|---|---|---|---|---|---|---|---|---|
| Salmonella spp. (35) | 30(85.7%) | 24(68.6%) | 26(74.3%) | 12(34.3%) | 5(14.3%) | 10(28.6%) | 15(42.9%) | 9(27.5%) |
| Sero-group D (17) | 15(88.2%) | 11(64.7%) | 14(82.4%) | 7(41.2%) | 3(17.6%) | 6(35.3%) | 9(52.9%) | 5(29.4%) |
| Sero-group C (12) | 10(83.3) | 8(66.6%) | 8(66.7%) | 4(33.3%) | 2(16.7%) | 3(25%) | 4(33.3%) | 3(25%) |
| Sero-group B (6) | 5(83.3%) | 4(66.7%) | 4(66.7%) | 1(16.7%) | 0(0%) | 1(16.7%) | 3(50%) | 1(16.7%) |
AMP ampicillin, TMP–SXT trimethoprim sulfamethoxazole, AMX amoxicillin, K kanamycin, CIP ciprofloxacin, CRO ceftriaxone, NA nalidixic acid, C chloramphenicol, CN gentamicin, AMK amikacine, TTC tetracycline